Royalty Pharma plc

NASDAQ:RPRX

27.99 (USD) • At close September 19, 2024
Bedrijfsnaam Royalty Pharma plc
Symbool RPRX
Munteenheid USD
Prijs 27.99
Beurswaarde 12,543,214,680
Dividendpercentage 2.89%
52-weken bereik 25.2 - 31.655
Industrie Biotechnology
Sector Healthcare
CEO Mr. Pablo Gerardo Legorreta
Website https://www.royaltypharma.com

An error occurred while fetching data.

Over Royalty Pharma plc

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research

Vergelijkbare Aandelen

Seagen Inc. logo

Seagen Inc.

SGEN

228.74 USD

DexCom, Inc. logo

DexCom, Inc.

DXCM

71.92 USD

Biogen Inc. logo

Biogen Inc.

BIIB

201.44 USD

IDEXX Laboratories, Inc. logo

IDEXX Laboratories, Inc.

IDXX

517.06 USD

Align Technology, Inc. logo

Align Technology, Inc.

ALGN

257.17 USD

Hologic, Inc. logo

Hologic, Inc.

HOLX

82.4 USD

ICON Public Limited Company logo

ICON Public Limited Company

ICLR

300.92 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)